EMA Authorised: Dovato (dolutegravir sodium;lamivudine) — ViiV Healthcare B.V.

View source ↗

Summary

The European Medicines Agency has authorised Dovato, a fixed-dose combination tablet of dolutegravir and lamivudine, from ViiV Healthcare for the treatment of H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dovato (dolutegravir/lamivudine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare B.V.. Decision date: 16/10/2025